Autologus tissue repair can be defined as transplantation of tissue from one place to another (body parts) of an individual. Tissue engineering has gained impetus after the introduction of stem cells. Stem cell has the desirable properties of self renewal and distinctive plasticity makes it a popular choice for autologus tissue engineering methods. For, instance it is difficult to expand a somatic cell in sufficiently large numbers in ex vivo condition but it can be overcome by the use of stem cells. Current clinical application of autologus tissue repair includes cardiac repair, neural repair, bone repair, skeletal muscle repair and pediatric vascular conduits.
Obtain Report Details @
Globally aging population is on the rise significantly and intractable ailments are very common among aged population globally. Hence, autologus tissue repair remains an ultimate choice for the treatment of intractable ailments among the elderly population. Thus, with the aging population the global market for autologus tissue repair is also expected to increase. Moreover it has been observed that autologus tissue repair has been utilized in almost all kind of surgical producers. Wound care and orthopedic application segment is the most promising market in the global autologus tissue repair. This is due to frequent increase of road accidents and increasing prevalence of diabetic patients. Nearly 1.24 million death occurs due to traffic accident every year globally as stated by the WHO. Moreover, increasing fatal and non-fatal accident globally and will also accentuate the global autologus tissue repair market. In addition diabetes is a common public health problem worldwide. International Diabetes Federation published in 2013, that the prevalence of diabetes in the global population was 382 million. Technological advancement which helps in production of innovative products is also expected to accentuate the global market for autologus tissue repair. However stringent regulatory compliance pertaining to autologus tissue repair would restrict the global demand of the autologus tissue repair. In addition high cost associated with autologus tissue repair is also a crucial factor that can restrict the global autologus tissue demand.
North America is observed to be the largest autologus tissue repair market due to presence of major market players based in this region. Europe is expected to record the second position in the global market owing to large geriatric population base in European countries. Asian and Latin American regions will be fuelled by the presence of untapped opportunities due to extensive increase in the healthcare infrastructure and high industrialization rate in the future. Asia-Pacific is being considered as an emerging market due to growing market penetration of in this region that is expected to exhibit a highest CAGR during the forecast period. Moreover, the market for autologus tissue repair in Asia-Pacific will be also fuelled due to strong economic growth forecasted (healthcare infrastructure, healthcare facility and product expansion) in some Asian countries such as India, China, Japan and Malaysia.
Fill the form for an exclusive sample of this report @
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.